Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Putting drug abuse research to use in real-life settings.

Hanson GR, Leshner AI, Tai B.

J Subst Abuse Treat. 2002 Sep;23(2):69-70. No abstract available.

PMID:
12220602
2.

Recent advances in the dissemination of contingency management techniques: clinical and research perspectives.

Petry NM, Simcic F Jr.

J Subst Abuse Treat. 2002 Sep;23(2):81-6. Review.

PMID:
12220605
3.

The role of organization and management in substance abuse treatment: Review and roadmap.

D'Aunno T.

J Subst Abuse Treat. 2006 Oct;31(3):221-33. Epub 2006 Aug 24. Review.

PMID:
16996385
4.

New anticonvulsants: a review of applications for the management of substance abuse disorders.

Gentry JR, Hill C, Malcolm R.

Ann Clin Psychiatry. 2002 Dec;14(4):233-45. Review.

PMID:
12630659
5.

A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.

Brunette MF, Mueser KT, Drake RE.

Drug Alcohol Rev. 2004 Dec;23(4):471-81. Review.

PMID:
15763752
6.

Incorporating brain research findings into standard treatment: an example using the Matrix Model.

Obert JL, London ED, Rawson RA.

J Subst Abuse Treat. 2002 Sep;23(2):107-13. Review.

PMID:
12220608
7.

Learning and unlearning drug abuse in the real world: clinical treatment and public policy.

Crowley TJ.

NIDA Res Monogr. 1988;84:100-21. Review. No abstract available.

PMID:
3147378
8.

Evidence for substance abuse services and policy research: a systematic review of national databases.

Coffey RM, Levit KR, Kassed CA, McLellan AT, Chalk M, Brady TM, Vandivort-Warren R.

Eval Rev. 2009 Apr;33(2):103-37. doi: 10.1177/0193841X08328126. Epub 2009 Jan 6. Review.

PMID:
19126788
9.

The challenges of conducting research in drug treatment court settings.

Belenko S.

Subst Use Misuse. 2002;37(12-13):1635-64. Review.

PMID:
12487237
10.

A decade of drug treatment court research.

Turner S, Longshore D, Wenzel S, Deschenes E, Greenwood P, Fain T, Harrell A, Morral A, Taxman F, Iguchi M, Greene J, McBride D.

Subst Use Misuse. 2002;37(12-13):1489-527. Review.

PMID:
12487232
11.

Directions for practice and research.

Leukefeld CG, Tims FM.

NIDA Res Monogr. 1992;118:279-93. Review. No abstract available.

PMID:
1620223
12.

[Disease and drug abuse. Current problems in drug safety].

Ecker-Schlipf B.

Med Monatsschr Pharm. 1987 Aug;10(8):254-61. Review. German. No abstract available.

PMID:
3312980
13.

Why evaluate for residual drug effects.

Spencer JW.

NIDA Res Monogr. 1990;101:1-9. Review. No abstract available.

PMID:
2092208
14.

Perspectives of neuroimmune issues and substances of abuse.

Sharp CW.

J Neuroimmunol. 1998 Mar 15;83(1-2):1-3. Review. No abstract available.

PMID:
9610667
15.

Substance use disorders: do males and females have differential vulnerability?

Broome MV, Hurley RA, Taber KH.

J Neuropsychiatry Clin Neurosci. 2010 Summer;22(3):iv. doi: 10.1176/appi.neuropsych.22.3.iv. Review. No abstract available.

PMID:
20686131

Supplemental Content

Support Center